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Since the 1980s, the incidence of severe pulmonary hemorrhage caused by Leptospira
spp. infection has increased. The mild, non-speciﬁc symptoms or the more classical form
of severe disease with hepatorenal manifestations, Weil’s syndrome, predominate world-
wide. However, several regions of the world have seen increases in numbers of patients
with pulmonary hemorrhage attributed to leptospirosis.The reasons behind the emergence
of this syndrome, which carries a high mortality rate, are not known. Several avenues for
future research may shed light on the mechanisms involved in development of pulmonary
hemorrhage, and inform targeted therapeutics to improve outcomes. Possibilities to con-
sider include: (1) emergence of new bacterial strains, (2) acquisition of virulence traits by
strains in the endemic regions, (3) changes in underlying health of the affected human pop-
ulations, and (4) increased recognition of the syndrome and better record keeping by the
medical and veterinary communities. Determining the causes of emerging clinical man-
ifestations presents challenges and opportunities for potentially life-saving research into
the pathogenesis of a number of infectious diseases, including leptospirosis.
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INTRODUCTION
Leptospirosis is the clinical manifestation of zoonotic infec-
tion by spirochetes of the genus Leptospira (reviewed in Adler
and de la Pena Moctezuma, 2009; see also http://www.who.int/
zoonoses/diseases/lerg/en/index.html). While several Leptospira
species can cause infection and disease in humans and animals,
the severity of disease is multifactorial. In humans, leptospiro-
sis may range from a very mild and self-limited illness to severe
multisystem illness that includes high fever, renal failure, jaundice,
and aseptic meningitis as well as a plethora of other signs and
symptoms. Weil’s syndrome, a severe leptospirosis manifestation,
is characterizedby renal failure, jaundice,and splenomegaly. Tradi-
tionally, those most at risk reside in tropical, developing countries,
although the disease is geographically widespread. Traditionally,
certain occupations, including farming/ranching, veterinary med-
icine, abattoir, or sewer work, place individuals at increased risk
of leptospirosis. Currently, however, leptospirosis is considered by
many to be a re-emerging infectious disease due primarily to expo-
sure to rats and their urine in urban slum settings, and exposure
through recreational activities and ﬂooding towater contaminated
by animal urine.
Severe pulmonary hemorrhagic leptospirosis (SPHL; Dolh-
nikoff et al., 2007) as a presentation of leptospirosis has also been
termed severe pulmonary hemorrhagic syndrome (SPHS;Ko et al.,
1999; Gouveia et al., 2008), severe pulmonary form of leptospiro-
sis (SPFL; Silva et al., 2002; Spichler et al., 2008; Marchiori et al.,
2011), and leptospiral pulmonary hemorrhage syndrome (LPHS;
Croda et al., 2010). SPHL has been recognized as an emerging clin-
ical manifestation over the last two decades. While hemorrhagic
and pulmonary manifestations of leptospirosis have long been
recognized (reviewed in Edwards and Domm, 1960; da Rocha
Medeiros et al., 2010), SPHL carries a high mortality rate, and
does not always coincide with the classic manifestations of severe
leptospirosis (Weil’s syndrome). On autopsy, patients with SPHL
generally have hemorrhagic and/or necrotic lesions in numerous
other sites (Chen et al., 2007; Spichler et al., 2007), suggesting that
SPHL might be simply the most easily, externally discernable sign
of generalized hemorrhage.
The manifestations of SPHL reported by several different
groups include dyspnea, crackles, and sometimes massive hemop-
tysis, radiographic ﬁndings such as alveolar inﬁltrates not associ-
ated with any particular lobes of the lung, and rapid deterioration
of the patient’s condition such that mechanical ventilation is
required (see Silva et al., 2002; Gouveia et al., 2008; Spichler et al.,
2008; Marchiori et al., 2011). Even with intensive supportive care
and antibiotic therapy,once SPHLhas developed,outcome is poor.
The reasons behind the emergence of SPHL are not yet known, but
are important to understand in order to decrease morbidity and
mortality in leptospirosis patients.
POSSIBLE MECHANISMS DRIVING THE EMERGENCE OF
SPHL
Possibilities to consider regarding the emergence of SPHL are
manifold. Certain Leptospira species and serovars are endemic to
particular regions, although introduction of a new strain can cause
increased rates of leptospirosis in endemic regions (Thaipadung-
panit et al., 2007). Although this cannot be directly tested, many
in the ﬁeld believe that certain Leptospira species and serovars
(Leptospira interrogans serovars Copenhageni, Icterohaemorrha-
giae, Lai) have tendencies to cause greater severities of disease in
humans (Faine et al.,1999;Adler andde laPenaMoctezuma,2009).
However, the geographic diversity of SPHL does not support
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the phenomenon being purely regional or attributable to any
speciﬁc leptospirosis agent. A number of different L. interro-
gans serovars have been associated with pulmonary hemorrhage
(Trevejo et al., 1998; Seijo et al., 2002; Vijayachari et al., 2008),
although it has been contested that overall there is poor corre-
lation between particular serovars and severity of leptospirosis
(Vinetz, 2001). Genome sequences have been published for sev-
eral leptospirosis agents, including L. interrogans Copenhageni
and Lai (Ren et al., 2003; Nascimento et al., 2004), as well as
two strains each of Leptospira borgpetersenii serovar Hardjo-bovis
(Bulach et al., 2006) and the saprophyte Leptospira biﬂexa serovar
Patoc (Picardeau et al., 2008). It is possible that, as additional
L. interrogans genome sequences are determined, polymorphisms
will be correlated with SPHL. In an ambitious undertaking aimed
at better understanding the pathogens of the genus Leptospira,
sequencing of approximately 200 different isolates is underway
(http://gsc.jcvi.org/projects/gsc/Leptospira/index.shtml).
Comparison of two L. borgpetersenii serovar Hardjo genome
sequences reveled interesting avenues to purse in future investi-
gations into the biology and pathogenesis of the genus Leptospira
(Bulach et al., 2006). Both strains are able to cause infection in
some host species, but hamster susceptibility to lethal infection
by the two strains differs. Both genomes are smaller than those of
L. interrogans serovars Lai and Copenhageni. The authors found
that most striking differences lie in genes that enable the bacteria
to survive in different environments, e.g., those whose products
are involved in biosynthesis and transport of nutrients, and in
regulation of gene expression. This affected the ability of L. borg-
petersenii Hardjo,as compared toL. interrogans, to survive inwater.
The ﬁndings of this work are also consistent with the epidemiol-
ogy, in that L. borgpetersenii appears to require direct transmission
to new hosts.
As genome sequencing becomes more rapid and facile for min-
imal cost, the focus will need to evolve to identifying functions for
predicted hypothetical proteins and those known to be produced,
but for which no function is known. It is possible that, within any
geographic region, there are clones belonging to a single species
and serovar that have emerged with heightened virulence due to
altered genome sequences. The large sequencing project will be
particularly informative inn this regard. This would be one exam-
ple of independent convergent evolution, although it is difﬁcult to
discern how causing SPHS would beneﬁt organisms that rely on
maintenance of infection in reservoir hosts. It is possible, however,
that such mutations may have minimal or even beneﬁcial effects
on the organisms in non-human environments.
To deﬁnitively determine the importance of any candidate
virulence attribute, the genetic basis of Leptospira species viru-
lence will need to be determined at the level of gene function
and regulation. Recent developments in the genetic manipula-
tion of Leptospira species (Bauby et al., 2003; Bourhy et al., 2005;
Louvel and Picardeau, 2007; Croda et al., 2008; Ko et al., 2009;
Murray et al., 2009; Aviat et al., 2010; Poggi et al., 2010) will facil-
itate identiﬁcation of genes whose products are essential for, or
contribute to, pathogenesis of leptospirosis. In a groundbreaking
demonstration of the power of this approach, the gene encoding
an OmpA-like outer membrane protein, loa22, was demonstrated
to contribute to the ability of L. interrogans serovar Lai to cause
disease in hamsters and guinea pigs (Ristow et al., 2007). Recom-
binant Loa22 is reported to have a number of effects on rat kidney
cells in culture (Zhang et al., 2009), but the biological signiﬁcance
is difﬁcult to discern at this point. More recently, a nudix hydrolase
was shown to contribute to virulence of L. interrogans serovar Lai
in hamsters (Luo et al., 2011). Interesting additional candidates
to pursue will include the putative sphingomyelinases annotated
in the genome, the pore-forming toxin SphH (Lee et al., 2000,
2002), and the adhesins that mediate attachment to host mole-
cules (Merien et al., 2000; Palaniappan et al., 2002; Matsunaga
et al., 2003; Barbosa et al., 2006; Verma et al., 2006; Choy et al.,
2007; Stevenson et al., 2007; Atzingen et al., 2008).
It is possible that some of the disease manifestations will even-
tually be linked to particular virulence attributes, and to proteins
responsible for direct damage or for expression of particular genes
or regulons. A possible route for investigation of the effects of
possible leptospiral disruption of cells or tissues comes from work
published by Croda et al. (2010), which demonstrated that, in
lungs of patients who died of severe leptospirosis, pulmonary
hemorrhage correlated with deposits of immunoglobulins and
complement component C3. Deposits of immunoglobulins and
C3 were not seen in patients with non-leptospirosis associated
pulmonary hemorrhage. This phenomenon was ﬁrst noted in the
guinea pig model of leptospirosis (Nally et al., 2004), and together
the ﬁndings suggest a signiﬁcant role for the immune response
in the development of SPHL. However, the early presentation of
SPHL might suggest that direct damage by bacterial factors may
play a role (Silva et al., 2002; Vijayachari et al., 2008). In vitro,
L. interrogans serovars Canicola and Copenhageni were demon-
strated to disrupt endothelial layers in culture (Martinez et al.,
2010). The mechanisms of damage underlying these ﬁndings will
be interesting to investigate.
In addition to polymorphisms in gene sequences, strain-to-
strain variations may also be due to mutations that affect reg-
ulation of virulence gene expression and protein production, or
due to acquisition of additional genomic sequences from other
organisms. Since leptospirosis is a zoonotic infection that is often
water-borne, there are abundant opportunities for leptospires to
interact with other microorganisms and perhaps to exchange
genetic information. Given the widespread geographic distribu-
tion of SPHL, however, it is does not appear likely that acquisition
of any particular new genetic element is the underlying reason for
the emergence of this leptospirosis manifestation, unless a donor
species can be demonstrated to survive in similar environments
world-wide. It has been demonstrated, however, that E. coli can
transfer a derivative of a broad host-range conjugal plasmid to L.
interrogans and L. biﬂexa in the laboratory (Picardeau, 2008), so
the possibility does exist.
Further understanding of the host side of the Leptospira–
human interaction in the emergence of SPHL will also merit
further investigation. The patients affected by SPHL have not been
consistently found to have signiﬁcant gender bias apart from the
historic overall male bias in leptospirosis that is in part due to
the occupations and activities that increase risk for leptospirosis.
One notable exception to this trend is that in Salvador, Brazil,
Gouveia et al. (2008) reported that, although male patients pre-
dominated in the study population, female patients had a higher
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risk of developing SPHL. SPHL is seen in previously healthy adults
and children, suggesting that age is not a signiﬁcant factor in SPHL
development, but may affect the fatality rate (Marotto et al., 1997).
Reports from Brazil, France, India, Israel, Korea, Nicaragua, Peru,
Taiwan, Thailand, and Vietnam document SPHL as a manifes-
tation of leptospirosis (Park et al., 1989; Zaki and Shieh, 1996;
Marotto et al., 1997; Borer et al., 1999; Chen et al., 2007; Spich-
ler et al., 2007, 2008; Gouveia et al., 2008; Vijayachari et al., 2008;
Clavel et al., 2010), although the rates have varied in the different
studies and locations. One study has identiﬁed a possible genetic
link to susceptibility to leptospirosis (not SPHL, speciﬁcally; Lin-
gappa et al., 2004). In this set of patients in a large US outbreak
among triathletes, an association was found between HLA-DQ6
plus ingestion of lake water and leptospirosis. This ﬁnding has
not yet been further tested in other, larger outbreaks, such as that
in Manila, Philippines in the fall of 2010. The HLA-DQ6–water
ingestion–leptospirosis association may also be a function of the
particular species and serovar that caused the outbreak. It is there-
fore not yet clear whether genetic traits in the human population
in any particular location play signiﬁcant roles in susceptibility to
SPHL or any other manifestation of leptospirosis. Given the com-
plexity of leptospirosis, and the lack of co-incidence between SPHL
and the more classical severe leptospirosis signs and symptoms
(Weil’s syndrome), no data yet suggest that SPHL is obligatorily
tied to any other disease manifestation except thrombocytopenia
and oliguria (Park et al., 1989; Thammakumpee et al., 2005; Spich-
ler et al., 2008), or to genetic variations in the human population.
Changes in the underlying health and immune status in the
affected human populations may also contribute to the emer-
gence of any disease, including SPHL. For example, Vijayachari
et al. (2004, 2008) suggested that having previous exposure,
thus seropositivity, reduces the severity of the disease. However,
seropositivity does not necessarily equal protective immunity, and
it is possible that seropositivity will not be a good predictor of
any particular severe disease manifestation over time and in all
locations. An additional possibility is that previous subclinical
exposure to one serovar may worsen disease caused by a differ-
ent serovar if the immune system is dysregulated, analogous to
the situation for Dengue. Many cases of SPHL are acute, occurring
within 1week of onset of symptomatic illness (the classical“septic”
phase), which, if host immunity is found to play a role, might sug-
gest future investigations of possible recall responses or the role of
the innate immune system in the development of SPHL. The ﬁnd-
ings of antibody and complement deposit in the alveoli of humans
and guinea pigs suggest a possible role for natural antibodies. It
is possible that non-switched IgM antibodies are the pathogenic
determinants in these antibody and complement deposits, as it
has been demonstrated that the early response to relapsing fever
Borrelia is dependent on non-T-cell dependent B1b lymphocytes
and IgM production (Alugupalli et al., 2003, 2004).
One possibility for future investigation is polymorphisms in
human cytokine-encoding genes or their regulatory elements. One
example that will be interesting to pursue is sST2, a soluble mem-
ber of the IL-1 receptor family. Elevated levels of sST2 were associ-
ated with severe hemorrhage in a series of severe leptospirosis
patients (Wagenaar et al., 2009). Interestingly, sST2 was not
induced by leptospires added to peripheral blood, suggesting
that either the cell type responsible for sST2 production was not
present, or that the activity of a human or bacterial molecule was
inhibited by the heparin used in the blood draw.
Of further interest in future work will be the recognition of
Leptospira LPS by both TLR2 and TLR4. Previous studies have
Implicated TLRs 2, 4, and 5 in human responses to leptospires
(Goris et al., 2011). In intact leptospires, the lipid moieties rec-
ognized by TLRs 2 and 4, and the ﬂagella classically recognized
by TLR5, are not available for recognition, so it is likely that the
activation occurs after phagocytosis of the organism by innate
defense cells. These receptors apparently also participate in the
phagocytosis itself, as previous work has demonstrated the impor-
tance of TLR4 in controlling bacterial load and development of
severe leptospirosis in mice (Viriyakosol et al., 2006). TLR2 has
similarly been implicated in controlling the burden and spread of
a variety of other organisms (Wooten et al., 2002; Mancuso et al.,
2004; Malik et al., 2006; Abplanalp et al., 2009). The leptospiral
protein LipL32, which is common to the pathogenic species, was
reported to bind to TLR2 (Hsu et al., 2010), which is a novel
activity for both the TLR and for the LipL32, which was previ-
ously shown to bind ﬁbronectin (Hoke et al., 2008). These hints of
interesting and novel aspects of leptospiral interactions with host
defenses will likely provide signiﬁcant opportunities for research
into mechanisms of disease development in leptospirosis.
Severe pulmonary hemorrhagic leptospirosis emergence does
coincide to at least some extent with the growth of urban slums
in tropical cities. Segura et al. (2005) documented pulmonary
involvement in urban but not rural patients in Brazil. There are
several possible reasons why this demographic shift may affect the
incidence of SPHL. First, the incidence of leptospirosis due to con-
tact with rats and their urine may play a signiﬁcant role, as rats are
maintenance hosts for L. interrogans serovars that are particularly
pathogenic in humans (Demers et al., 1983, 1985; Vinetz et al.,
1996; Adler and de la Pena Moctezuma, 2009). When the disease
was more common in rural settings, the serovars and maintenance
species were often different.
Second, as has been documented previously, the exposure to
leptospires may be higher in the urban slum setting than in the
more classical rural setting. In fact, Reis et al. (2008) documented
higher risk of leptospirosis, as measured by evidence of exposure
by antibody testing, among those living at the bottom of the socio-
economic ladder within slums. Ganoza et al. (2006) found higher
numbers of human-pathogenic leptospires in urban water sources
than in rural settings in Peru. While not all leptospirosis risk stud-
ies address rates of particular signs and symptoms, determining
whether disease severity correlates with exposure levels or routes
may provide important information in future studies. In a differ-
ent slum population in Brazil, Spichler et al. (2008) did not ﬁnd a
signiﬁcant difference in leptospirosis survivors vs. non-survivors
in environmental exposures.
Delays in treatment, common to poor populations in the devel-
opingworld, and the inoculum sizemay be determinants for devel-
oping pulmonary hemorrhage (Dolhnikoff et al., 2007). In most
endemic areas, other illnesses that are also endemic may cloud
diagnosis, contributing to effective treatment delays. However,
some cases had rapid development of pulmonary hemorrhage
after hospital admission with a brief history (days) of non-speciﬁc
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illness. Measures to reduce the leptospiral burden in reservoir ani-
mals, and therefore in the environment, as well as investigations of
leptospiral gene products and attributes critical to their survival
in the environment, can be areas of focus for future work. More
readily available health care and diagnostic approaches will also
likely reduce the incidence of severe disease in endemic areas.
A critical contribution to understanding SPHL will be the
increased recognition of the syndrome and more detailed record
keeping by the medical community. This is now a priority for the
governments of some of the affected regions, and novel meth-
ods of surveillance are being implemented (Spichler et al., 2007,
2008) to assess the frequencies of different manifestations of lep-
tospirosis. Most importantly, increased access to health care for at
risk populations will increase the likelihood of survival of severe
leptospirosis, including SPHL.
QUESTIONS TO ADDRESS IN FUTURE INVESTIGATIONS
With current limited information on how Leptospira species
cause infection and disease, it is difﬁcult to distinguish the risk
factors and virulence factors that separate SPHL from other lep-
tospirosis manifestations. One priority for future research in
leptospirosis will be the identiﬁcation of speciﬁc virulence fac-
tors that contribute to the ability of Leptospira species to cause
infection and disease, which are not equivalent. This will be
greatly facilitated by the continuing development of genetic tools
for Leptospira species and small animal models of human lep-
tospirosis, as well as by genome sequencing. Additional research
will need to be done at the epidemiologic level, to determine
whether SPHL can be associated with speciﬁc environmental
or socio-economic factors in the future, as has been published
for leptospirosis in general (Reis et al., 2008). Similar inves-
tigations will also need to be performed at the patient care
level, to determine whether the emergence of SPHL is in part
due to better recognition of this manifestation as a possibil-
ity in leptospirosis (even in the absence of Weil’s syndrome),
and to determine whether novel therapeutic approaches can
augment antibiotic therapy and supportive care of critically ill
patients.
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